Utah Medical Announces Self-Tender Offer to Repurchase 20% of Shares at Premium

Key Facts

1Utah Medical Products intends to repurchase up to 650,000 shares at a price of $75.00 per share.

2The tender offer represents approximately 20% of the company's currently outstanding shares.

3The $75.00 offer price is 17% higher than the average daily closing price over the last twelve months.

In a strategic move to return capital to its investors, Utah Medical Products has launched a self-tender offer to repurchase a significant portion of its equity. The company intends to buy back up to 650,000 shares, representing approximately 20% of its currently outstanding stock. The offer price is set at a fixed $75.00 per share, which reflects a 17% premium over the average daily closing price recorded during the last twelve months.

Per market data, UTMD shares closed at $70.67 on September 14, 2026, positioning the $75.00 offer price above recent trading levels. During the September 14 session, the stock reached a high of $71.26 and a low of $69.49. This corporate action utilizes a self-tender mechanism to provide shareholders with an opportunity to realize gains at a premium relative to historical trading averages.

Traders should watch for price consolidation near the offer level, with UTMD at $70.67 (close September 14, 2026). While the upcoming economic calendar shows no direct catalysts for the medical device sector, broader market sentiment remains influenced by recent data, such as the US Producer Price Index which showed a 0.4% monthly increase on September 10.